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Background: Primary ciliary dyskinesia (PCD) and humoral mmunodeficiency (HID) are both
rare disorders which cause recurrent upper and lower respiratory tract infections.
Objective: To examine the concurrence of PCD and HID in a patient cohort with known PCD.
Methods: Retrospective review of the patient files.
Results: We describe 11 patients of a cohort of 168 patients with PCD (6.5%) with a combina-
tion of PCD and some form of HID. The patients all presented with typical clinical symptoms for
PCD, however the role of the concomitant immunological abnormalities is not clear.
Conclusion: PCD and HID coincided in 6.5% of the patients. We suggest that a common patho-
physiological pathway results in both disorders.
ª 2014 Elsevier Ltd. All rights reserved.Introduction
Primary ciliary dyskinesia (PCD) is a rare disorder (preva-
lence 1/20.000), caused by congenital dysmotility of the
motile cilia. It is mainly inherited in an autosomal recessiveof Pediatrics, Pediatric Pul-
Herestraat 49, 3000 Leuven,
2 16343842.
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hts reserved.manner, but up till now more than 20 different genes have
been reported [1]. Patients with PCD present with recurrent
upper and lower respiratory tract infections, leading to
bronchiectasis and chronic lung disease and rarely respira-
tory insufficiency [1]. Humoral immunodeficiency (HID) is
another common cause of recurrent infections of the upper
and lower respiratory tract. Common variable immunodefi-
ciency disorder (CVID) is a rare (prevalence around 1/
75.000) entity, characterized by hypogammaglobulinemia,
defective specific antibody production and an increased
susceptibility to recurrent infections [2]. Selective IgA defi-
ciency and isolated IgG subclass deficiency (IgG2 or IgG3
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and in some patients they are the only identifiable cause of
recurrent respiratory tract infections. However, the rele-
vance of these findings has been discussed [3]. Isolated
subclass deficiencies have been reported in up to 2% of a
healthy population, without any clinical symptom [4].
Finally, specific polysaccharide antibody deficiency (SPAD)
points to patients with a specific defect in the generation of
antibodies to polysaccharides [5].
However unexpected, there is one report of a concom-
itant presentation of both disorders [6].Methods
We retrospectively reviewed the files of our patients with
PCD and examined the concurrence of PCD and HID. PCD
was defined as abnormal ciliary motility after ciliogenesis
in vitro with or without ultrastructural abnormalities. This
technique excludes secondary ciliary dyskinesia due to
infections or toxic substances and is able to reliably detect
PCD with normal ultrastructure [7,8]. For patients with
PCD and normal ultrastructure, genetic analysis of DNAH11
was performed if DNA of the patient was available. In
selected patients with PCD due to dynein deficiency, ge-
netic analysis of DNAH5 was performed. HID was defined
as a value more than 2 SDs below the normal mean for age.
SPAD was defined as poor response to unconjugated
pneumococcal vaccine: a less than twofold increase in
antibody titers in 50% of the tested serotypes indicates a
poor response [9]. The indication for checking immuno-
globulin status was extensive respiratory symptoms in all
of the patients. Patients were clinically stable at the
moment of sampling. Hence, there was no acute infection,
but a state of chronic infection as is often the case in
patients with PCD. Clinical data were derived from the
patient files. Lung function results (if available) are
expressed as % predicted of FEV1.Results
For 168 patients with proven PCD, immunoglobulin levels
were available in 96, IgG subclasses in only 68. Abnormal
results for one or more antibody or antibody subclass were
found in 11/68 (16.1% or 6.5% of the total cohort).
Table 1 presents the clinical, ultrastructural and genetic
presentation of PCD and the type of HID. When compared to
an age-matched control group of patients with PCD without
HID, FEV1 was not significantly lower (median 75.6% versus
83.9%, p 0.508, related-samples Wilcoxon signed rank test).
However 6/11 (54%) patients have intermittent or chronic
infection with Pseudomonas aeruginosa, as opposed to only
22/157 (14%) in those without HID (c2 p 0.003).Discussion
The fact that PCD concurs with HID in 16.1% (6.5% of the
total cohort) is striking, but might be coincidental. Several
causal hypotheses can be postulated. 1) Although he-
matopoietic cells are one of the few cell types that lack
primary cilia, they express intraflagellar transport proteins
needed for the formation of the immune synapse [10] and
dysfunction might cause PCD as well as HID. 2) Ciliary
epithelial cells are shown to have an antigen-presenting
function [11] and therefore antigen presentation might
be disturbed in PCD. On the other hand nasal epithelial
cells might have an immunomodulatory effect on specific
IgA and IgG antibody response [12] and therefore antibody
responses might be disturbed in PCD. 3) Dysfunction of
inducible nitric oxide synthase (iNOS) has been postulated
as a possible mechanism of low nasal NO values in PCD
[13], and iNOS is involved in IgA class-switch recombina-
tion in mice [14]. Therefore dysfunction of iNOS could play
a role in both disorders. 4) Increased immunoglobulin
consumption due to chronic infection. 5) PCD could cause
cytokine dysfunction disturbing the immunoglobulin
maturation. 6) PCD genes could act as modifier genes for
HID genes or vice versa. The fact that two sibling pairs
present with PCD and HID supports the constitutional
origin of the findings.
Not all PCD cases in our cohort have been tested for
antibody deficiency, although it is suggested to rule out
immune dysfunction prior to start a workup for PCD [15].
However, in selected patients the history is more suggestive
of PCD, i.e. when situs inversus, infertility or neonatal
respiratory problems are present and thus immunological
screening is not performed systematically.
It is unclear whether antibody deficiency influences
outcome, but since 5/11 patients are treated with
replacement therapy this may impact outcome.
Although we lack clear proof of a link, we recommend to
check antibody titers in patients with PCD. The diagnosis of
HID can be important since immunoglobulin substitution is
an effective treatment in selected patients.Author’s contribution
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Table 1 Clinical, ultrastructural and genetic presentation of PCD, type of immunodeficiency and laboratory result ients with PCD and immunodeficiency.
Patient Age
(y)
Clinical presentation Sputum
bacteriology
Ultrastructural
defect
Genetic
diagnosis
Immuno
deficiency
Laboratory results (before start of re t therapy) Treatment
HID
SI N C B CR E FEV1
(% pred)
IgG (g/l) IgG2 (g/l) IgG3 (g/ (g/l) IgM (g/l) Polysaccharide
antibodies (before-
after vaccination)
(U/ml)
1 62 Y $ Y Y Y N $ Chronic
Pseudomonas
aeruginosa
Normal
ultrastructure
$ Low IgG
and low
IgG2
6.64
(7.51e15.6)
1.14
(1.5e6.4)
0.96
(0.2e1.1 2e4.53)
2.71
(0.46e3.04)
Intermittent
IVIG
2 7 N Y Y Y Y Y 104 No pathogens ODA
deficiency
$ Low IgG 5.48
(5.58e12.54)
1.00
(0.85e4.10)
0.21
(0.13e1 9e3.84)
0.49
(0.34e1.42)
3* 13 Y Y Y Y Y Y 75.9 Intermittent
Pseudomonas
aeruginosa
Normal
ultrastructure
Homozygous
DNAH11
mutation
Low IgA,
IgM, IgG2
and IgG3
7.54
(6.35e14.89)
0.5
(0.63e3.0)
0.13
(0.17e0
9
6e2.51)
0.23
(0.47e2.2)
Pn type 3 33 114 SCIG
Pn type 4 38 23
Pn type 9N 6 33
4* 16 N Y Y Y Y N 73.6 Intermittent
Pseudomonas
aeruginosa
Normal
ultrastructure
Homozygous
DNAH11
mutation
Low
IgA, IgM
and IgG2
8.55
(4.78e11.29)
0.38
(0.72e3.4)
0.27
(0.13e1 5e1.9)
0.41
(0.34e1.34)
Pn type 3 26 57 SCIG
Pn type 4 8 54
Pn type 9N 7 66
5 10 N N Y Y Y Y 75.3 Intermittent
Pseudomonas
aeruginosa
ODA
deficiency
$ Low IgA
and IgG3
7.39
(5.3e13.06)
1.47
(0.98e4.80)
0.08
(0.15e1
8
0e2.70)
0.53
(0.43e1.73)
6 39 Y $ Y Y Y Y 23 Intermittent
Pseudomonas
aeruginosa
ODA
deficiency
$ Low IgA 21.9
(7.51e15.6)
11.8
(1.5e6.4)
0.7
(0.2e1.1
.03
2e4.53)
1.02
(0.46e3.04)
7# 10 Y N Y Y Y Y 99.7 No pathogens Normal
ultrastructure
Biallelic
DNAH11
mutation
Low IgA 14.5
(5.3e13.06)
1.27
(0.98e4.8)
0.59
(0.15e1
9
e2.7)
2.56
(0.43e2.7)
8# 14 N Y Y Y Y Y 111 Intermittent
Pseudomonas
aeruginosa
Normal
ultrastructure
Biallelic
DNAH11
mutation
Low IgA 12.6
(5.76e12.65)
6
1e2.32)
1.28
(0.3e1.59)
9 33 Y $ Y Y Y Y 22 $ ODA and IDA
deficiency
One DNAH5
mutation
Low IgG2
and IgG3
8.3 (7e16) 1.8
(2.42e7.0)
0.18
(0.22e1 e4.0)
0.37
(0.4e2.3)
SCIG
10 43 N Y Y Y Y N 58.6 $ Normal
ultrastructure
$ Low IgG3 9.34
(7.51e15.6)
3.38
(1.50e6.40)
0.11
(0.20e1
Intermittent
IVIG
11 32 N Y Y Y Y Y 107.5 No
pathogens
Central pair
absent
$ Low IgG3 14.0
(7.51e15.6)
4.06
(1.17e7.47)
0.29
(0.41e1
Median
75.6%
2 cases,
1 isolated
4 cases,
no isolated
5 cases,
2 isolate
ses,
olated
2 cases,
no isolated
2 cases, no isolated
B: bronchiectasis. C: chronic cough. CR: chronic rhinosinusitis. E: recurrent ear infections. IDA: inner dynein arm. IVIG: intravenous immunoglobulin. N: ne spiratory problems. ODA: outer dynein arm. SCIG: subcutaneous
immunoglobulin. SI: situs inversus. SPAD: specific polysaccharide antibody deficiency. *siblings, # siblings. $ no data available. Normal reference values ed between brackets, abnormal values are marked in bold and
underlined.
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(0.8
.42)
0.54
(0.2
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